INDIA BUSINESS WORLD OCTOBER (1^st - 20^th) 2007
The Month that was ...

LUPIN RECEIVES RS 112 CRORE FOR SELLING PERINDOPRIL PATENT

Pharmaceutical company Lupin has said it has received Euro 20 million (Rs 111.63 crore) from French firm Laboratoires Servier as proceeds of the sale of additional patent rights for Perindopril, a hypertension drug. "This income significantly boosts our performance for the current year. We are very pleased with the transaction and it goes a long way to further demonstrate our IP capabilities," Lupin managing director Kamal K Sharma said in a filing to the BSE. The EU market for perindopril is worth around $400 million.